Dishman Carbogen Amcis Limited (DCAL.BO)
INR 274.5
(-3.18%)
INR 274.5
(-3.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.14 Billion INR | -71.06% |
| 2022 | 17.78 Billion INR | 7.67% |
| 2021 | 16.51 Billion INR | 14.7% |
| 2020 | 14.4 Billion INR | 7.9% |
| 2019 | 13.34 Billion INR | 2.41% |
| 2018 | 13.03 Billion INR | 19.43% |
| 2017 | 10.91 Billion INR | -3.29% |
| 2016 | 11.28 Billion INR | 19.08% |
| 2015 | 9.47 Billion INR | 10.05% |
| 2014 | 8.61 Billion INR | 10.58% |
| 2013 | 7.78 Billion INR | 14.21% |
| 2012 | 6.81 Billion INR | 16.48% |
| 2011 | 5.85 Billion INR | 9.57% |
| 2010 | 5.34 Billion INR | 38.14% |
| 2009 | 3.86 Billion INR | -16.18% |
| 2008 | 4.61 Billion INR | 33.04% |
| 2007 | 3.46 Billion INR | 46.82% |
| 2006 | 2.36 Billion INR | 225.1% |
| 2005 | 726.57 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.16 Billion INR | 30.9% |
| 2023 Q4 | 891.2 Million INR | -84.43% |
| 2023 Q3 | 5.72 Billion INR | 22.68% |
| 2023 FY | 5.14 Billion INR | -71.06% |
| 2023 Q1 | 5.08 Billion INR | 29.74% |
| 2023 Q2 | 4.66 Billion INR | -8.3% |
| 2022 Q2 | 4.52 Billion INR | 4.16% |
| 2022 Q1 | 4.34 Billion INR | -6.74% |
| 2022 FY | 17.78 Billion INR | 7.67% |
| 2022 Q4 | 3.92 Billion INR | -21.18% |
| 2022 Q3 | 4.97 Billion INR | 9.98% |
| 2021 Q1 | 3.96 Billion INR | 24.62% |
| 2021 Q2 | 3.91 Billion INR | -1.26% |
| 2021 Q3 | 3.98 Billion INR | 1.89% |
| 2021 Q4 | 4.65 Billion INR | 16.78% |
| 2021 FY | 16.51 Billion INR | 14.7% |
| 2020 Q2 | 3.69 Billion INR | 3.83% |
| 2020 Q3 | 3.99 Billion INR | 8.1% |
| 2020 Q4 | 3.18 Billion INR | -20.48% |
| 2020 Q1 | 3.56 Billion INR | -3.22% |
| 2020 FY | 14.4 Billion INR | 7.9% |
| 2019 Q3 | 3.36 Billion INR | 8.13% |
| 2019 Q1 | 3.22 Billion INR | -29.8% |
| 2019 FY | 13.34 Billion INR | 2.41% |
| 2019 Q2 | 3.11 Billion INR | -3.47% |
| 2019 Q4 | 3.68 Billion INR | 9.36% |
| 2018 Q3 | 2.8 Billion INR | -4.06% |
| 2018 FY | 13.03 Billion INR | 19.43% |
| 2018 Q4 | 4.59 Billion INR | 63.86% |
| 2018 Q2 | 2.92 Billion INR | 7.49% |
| 2018 Q1 | 2.71 Billion INR | -1.24% |
| 2017 Q2 | 2.72 Billion INR | 0.18% |
| 2017 Q3 | 2.61 Billion INR | -4.28% |
| 2017 Q4 | 2.75 Billion INR | 5.36% |
| 2017 FY | 10.91 Billion INR | -3.29% |
| 2017 Q1 | 2.72 Billion INR | -2.36% |
| 2016 FY | 11.28 Billion INR | 19.08% |
| 2016 Q4 | 2.79 Billion INR | 14.49% |
| 2016 Q1 | 2.55 Billion INR | 4.88% |
| 2016 Q2 | 2.78 Billion INR | 9.03% |
| 2016 Q3 | 2.43 Billion INR | -12.55% |
| 2015 Q4 | 2.43 Billion INR | 12.41% |
| 2015 Q2 | 2.22 Billion INR | -5.05% |
| 2015 Q1 | 2.34 Billion INR | 1.82% |
| 2015 FY | 9.47 Billion INR | 10.05% |
| 2015 Q3 | 2.16 Billion INR | -2.59% |
| 2014 FY | 8.61 Billion INR | 10.58% |
| 2014 Q4 | 2.3 Billion INR | 9.64% |
| 2014 Q3 | 2.09 Billion INR | 2.02% |
| 2014 Q2 | 2.05 Billion INR | -3.05% |
| 2014 Q1 | 2.12 Billion INR | -9.25% |
| 2013 Q2 | 1.95 Billion INR | 14.55% |
| 2013 FY | 7.78 Billion INR | 14.21% |
| 2013 Q4 | 2.33 Billion INR | 24.9% |
| 2013 Q3 | 1.87 Billion INR | -4.29% |
| 2013 Q1 | 1.7 Billion INR | -11.85% |
| 2012 Q3 | 1.64 Billion INR | 4.69% |
| 2012 Q4 | 1.93 Billion INR | 17.96% |
| 2012 FY | 6.81 Billion INR | 16.48% |
| 2012 Q2 | 1.56 Billion INR | -5.37% |
| 2012 Q1 | 1.65 Billion INR | 5.57% |
| 2011 Q3 | 1.47 Billion INR | 0.0% |
| 2011 FY | 5.85 Billion INR | 9.57% |
| 2011 Q4 | 1.57 Billion INR | 6.68% |
| 2010 FY | 5.34 Billion INR | 38.14% |
| 2009 FY | 3.86 Billion INR | -16.18% |
| 2008 FY | 4.61 Billion INR | 33.04% |
| 2007 FY | 3.46 Billion INR | 46.82% |
| 2006 FY | 2.36 Billion INR | 225.1% |
| 2005 FY | 726.57 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | -415012.903% |
| Biocon Limited | 40.9 Billion INR | 87.416% |
| Blue Jet Healthcare Limited | 531.85 Million INR | -867.829% |
| Concord Biotech Limited | 1.45 Billion INR | -252.633% |
| FERMENTA BIOTECH LIMITED | 754.2 Million INR | -582.49% |
| GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -1372540.0% |
| Lyka Labs Limited | 599.4 Million INR | -758.749% |
| Panacea Biotec Limited | 1.99 Billion INR | -157.963% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | -343660.435% |
| Servoteach Industries Limited | 785.00 INR | -655719645.223% |
| SMS Lifesciences India Limited | 602.96 Million INR | -753.679% |
| Supriya Lifescience Limited | 1.08 Billion INR | -376.545% |
| Syngene International Limited | 5.99 Billion INR | 14.138% |
| TAKE Solutions Limited | 396.91 Million INR | -1196.868% |
| Titan Biotech Limited | 117.05 Million INR | -4297.345% |
| Transgene Biotek Limited | 5.39 Million INR | -95275.208% |
| Vanta Bioscience Limited | 38.95 Million INR | -13112.691% |